Abeera Mehmood

This record appears to combine work from multiple distinct research contexts, including clinical case reports on surgical and oncology topics (2018-2020) and more recent microbiology/immunology studies on gut bacteria, immune cells, and cancer immunotherapy (2023-2026). The most recent and heavily repeated publication concerns how a bacterial enzyme in Enterococcus faecium affects immune checkpoint inhibitor cancer therapy, alongside a study on immune cell responses to Norovirus and HIV-1 infection in humanized mouse models.

Publication output was sparse and irregular from 2017-2022, then increased sharply in 2024 (largely due to multiple entries tied to a single study, including preprints and peer review commentary), with an average of about 3 publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026